Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
AIDS and Behavior
Published in: AIDS and Behavior 3/2010

01-06-2010 | Original Paper

Behavior Change Interventions to Prevent HIV Infection among Women Living in Low and Middle Income Countries: A Systematic Review

Authors: Sandra I. McCoy, Rugare A. Kangwende, Nancy S. Padian

Published in: AIDS and Behavior | Issue 3/2010

Login to get access

Abstract

We conducted a systematic review of behavioral change interventions to prevent the sexual transmission of HIV among women and girls living in low- and middle-income countries. PubMed/MEDLINE, Web of Science, the Cochrane Library, and other databases and bibliographies were systematically searched for trials using randomized or quasi-experimental designs to evaluate behavioral interventions with HIV infection as an outcome. We identified 11 analyses for inclusion reporting on eight unique interventions. Interventions varied widely in intensity, duration, and delivery as well as by target population. Only two analyses showed a significant protective effect on HIV incidence among women and only three of ten analyses that measured behavioral outcomes reduced any measure of HIV-related risk behavior. Ongoing research is needed to determine whether behavior change interventions can be incorporated as independent efficacious components in HIV prevention packages for women or simply as complements to biomedical prevention strategies.
Literature
1.
UNAIDS. Report on the Global AIDS Epidemic. Geneva 2008.
2.
Pettifor AE, Rees HV, Kleinschmidt I, et al. Young people’s sexual health in South Africa: HIV prevalence and sexual behaviors from a nationally representative household survey. AIDS. Sep 23 2005;19(14):1525–34.
3.
Krishnan S, Dunbar MS, Minnis AM, Medlin CA, Gerdts CE, Padian NS. Poverty, gender inequities, and women’s risk of human immunodeficiency virus/AIDS. Ann N Y Acad Sci. 2008;1136:101–10.CrossRefPubMed
4.
Padian NS, van der Straten A, Ramjee G, et al. Diaphragm and lubricant gel for prevention of HIV acquisition in southern African women: a randomised controlled trial. Lancet. Jul 21 2007;370(9583):251–61.
5.
Skoler-Karpoff S, Ramjee G, Ahmed K, et al. Efficacy of Carraguard for prevention of HIV infection in women in South Africa: a randomised, double-blind, placebo-controlled trial. Lancet. Dec 6 2008;372(9654):1977–87.
6.
Peterson L, Nanda K, Opoku BK, et al. SAVVY (C31G) gel for prevention of HIV infection in women: a Phase 3, double-blind, randomized, placebo-controlled trial in Ghana. PLoS ONE. 2007;2(12):e1312.CrossRefPubMed
7.
Halpern V, Ogunsola F, Obunge O, et al. Effectiveness of cellulose sulfate vaginal gel for the prevention of HIV infection: results of a Phase III trial in Nigeria. PLoS ONE. 2008;3(11):e3784.CrossRefPubMed
8.
Turner AN, Morrison CS, Padian NS, et al. Men’s circumcision status and women’s risk of HIV acquisition in Zimbabwe and Uganda. AIDS. Aug 20 2007;21(13):1779–89.
9.
Wawer M, Kigozi G, Serwadda D, et al. Trial of male circumcision in HIV + men, Rakai, Uganda: effects in HIV+ men and in women partners. Paper presented at: 15th Conference on Retroviruses and Opportunistic Infections 2008; Boston, MA.
10.
National Institute of Allergy and Infectious Diseases. Workshop Summary: scientific Evidence on Condom Effectiveness for Sexually Transmitted Disease (STD) Prevention 2000.
11.
French PP, Latka M, Gollub EL, Rogers C, Hoover DR, Stein ZA. Use-effectiveness of the female versus male condom in preventing sexually transmitted disease in women. Sex Transm Dis. May 2003;30(5):433–9.
12.
Grosskurth H, Mosha F, Todd J, et al. Impact of improved treatment of sexually transmitted diseases on HIV infection in rural Tanzania: randomised controlled trial. Lancet. Aug 26 1995;346(8974):530–6.
13.
Kiwanuka SN, Ekirapa EK, Peterson S, et al. Access to and utilisation of health services for the poor in Uganda: a systematic review of available evidence. Trans R Soc Trop Med Hyg. Nov 2008;102(11):1067–74.
14.
Kalichman SC. Time to take stock in HIV/AIDS prevention. AIDS Behav. May 2008;12(3):333–4.
15.
Coates TJ, Richter L, Caceres C. Behavioural strategies to reduce HIV transmission: how to make them work better. Lancet. Aug 23 2008;372(9639):669–84.
16.
Herbst JH, Sherba RT, Crepaz N, et al. A meta-analytic review of HIV behavioral interventions for reducing sexual risk behavior of men who have sex with men. J Acquir Immune Defic Syndr. Jun 1 2005;39(2):228–41.
17.
Crepaz N, Horn AK, Rama SM, et al. The efficacy of behavioral interventions in reducing HIV risk sex behaviors and incident sexually transmitted disease in black and Hispanic sexually transmitted disease clinic patients in the United States: a meta-analytic review. Sex Transm Dis. Jun 2007;34(6):319–32.
18.
Darbes L, Crepaz N, Lyles C, Kennedy G, Rutherford G. The efficacy of behavioral interventions in reducing HIV risk behaviors and incident sexually transmitted diseases in heterosexual African Americans. Aids. Jun 19 2008;22(10):1177–94.
19.
Mullen PD, Ramirez G, Strouse D, Hedges LV, Sogolow E. Meta-analysis of the effects of behavioral HIV prevention interventions on the sexual risk behavior of sexually experienced adolescents in controlled studies in the United States. 302002:S94–105.
20.
Crepaz N, Lyles CM, Wolitski RJ, et al. Do prevention interventions reduce HIV risk behaviours among people living with HIV? A meta-analytic review of controlled trials. AIDS. Jan 9 2006;20(2):143–57.
21.
Noar SM. Behavioral interventions to reduce HIV-related sexual risk behavior: review and synthesis of meta-analytic evidence. 122008:335–53.
22.
Plummer ML, Ross DA, Wight D, et al. “A bit more truthful”: the validity of adolescent sexual behaviour data collected in rural northern Tanzania using five methods. Sex Transm Infect. Dec 2004;80 Suppl 2:ii49–56.
23.
Lagarde E, Auvert B, Chege J, et al. Condom use and its association with HIV/sexually transmitted diseases in four urban communities of sub-Saharan Africa. AIDS. Aug 2001;15 Suppl 4:S71–78.
24.
Cowan FM, Langhaug LF, Mashungupa GP, et al. School based HIV prevention in Zimbabwe: feasibility and acceptability of evaluation trials using biological outcomes. AIDS. Aug 16 2002;16(12):1673–8.
25.
Kamb ML, Fishbein M, Douglas JM, Jr., et al. Efficacy of risk-reduction counseling to prevent human immunodeficiency virus and sexually transmitted diseases: a randomized controlled trial. Project RESPECT Study Group. JAMA. Oct 7 1998;280(13):1161–7.
26.
Koblin B, Chesney M, Coates T. Effects of a behavioural intervention to reduce acquisition of HIV infection among men who have sex with men: the EXPLORE randomised controlled study. Lancet. Jul 3–9 2004;364(9428):41–50.
27.
Kamali A, Quigley M, Nakiyingi J, et al. Syndromic management of sexually-transmitted infections and behaviour change interventions on transmission of HIV-1 in rural Uganda: a community randomised trial. Lancet. Feb 22 2003;361(9358):645–52.
28.
Jewkes R, Nduna M, Levin J, et al. Impact of stepping stones on incidence of HIV and HSV-2 and sexual behaviour in rural South Africa: cluster randomised controlled trial. Bmj. 2008;337:a506.CrossRefPubMed
29.
Gregson S, Adamson S, Papaya S, et al. Impact and process evaluation of integrated community and clinic-based HIV-1 control: a cluster-randomised trial in eastern Zimbabwe. PLoS Med. Mar 27 2007;4(3):e102.
30.
Pronyk PM, Hargreaves JR, Kim JC, et al. Effect of a structural intervention for the prevention of intimate-partner violence and HIV in rural South Africa: a cluster randomised trial. Lancet. Dec 2 2006;368(9551):1973–83.
31.
32.
Pettifor AE, Kleinschmidt I, Levin J, et al. A community-based study to examine the effect of a youth HIV prevention intervention on young people aged 15–24 in South Africa: results of the baseline survey. 102005:971–80.
33.
Efficacy of voluntary HIV-1 counselling and testing in individuals and couples in Kenya, Tanzania, and Trinidad: a randomised trial. The Voluntary HIV-1 Counseling and Testing Efficacy Study Group. Lancet. Jul 8 2000;356(9224):103–12.
34.
Egger M, Smith GD, Altman DG, editors. Systematic reviews in health care: meta-analysis in context. 2nd ed. London: BMJ Publishing Group, BMJ Books; 2001.
35.
Rothman K. Epidemiology, an introduction. New York: Oxford University Press; 2002.
36.
Doyle A, Ross DA, Maganja K, Changalucha J, Hayes R, Team. atMkVT. Long-term impact of a behavioral change intervention on HIV, STI, knowledge, attitudes, and reported sexual behaviors among young people in rural Mwanza, Tanzania: results of a community randomized trial. 16th Conference on Retroviruses and Opportunistic Infections. Montreal, Canada 2009.
37.
Rothman KJ, Greenland S. Modern epidemiology. 2nd ed. Philadelphia: Lippincott Williams & Wilkins; 1998.
38.
Patterson TL, Mausbach B, Lozada R, et al. Efficacy of a brief behavioral intervention to promote condom use among female sex workers in Tijuana and Ciudad Juarez, Mexico. Am J Public Health. Nov 2008;98(11):2051–7.
39.
Archibald CP, Chan RK, Wong ML, Goh A, Goh CL. Evaluation of a safe-sex intervention programme among sex workers in Singapore. Int J STD AIDS. Jul–Aug 1994;5(4):268–72.
40.
Hargreaves JR, Bonell CP, Morison LA, et al. Explaining continued high HIV prevalence in South Africa: socioeconomic factors, HIV incidence and sexual behaviour change among a rural cohort, 2001–2004. AIDS. Nov 2007;21 Suppl 7:S39–48.
41.
Quigley MA, Kamali A, Kinsman J, et al. The impact of attending a behavioural intervention on HIV incidence in Masaka, Uganda. AIDS (London, England). 2004;18(15):2055–63.
42.
Ross DA, Changalucha J, Obasi AI, et al. Biological and behavioural impact of an adolescent sexual health intervention in Tanzania: a community-randomized trial. Aids. Sep 12 2007;21(14):1943–55.
43.
44.
Bhave G, Lindan CP, Hudes ES, et al. Impact of an intervention on HIV, sexually transmitted diseases, and condom use among sex workers in Bombay, India. Aids. Jul 1995;9 Suppl 1:S21–30.
45.
Matovu JK, Gray RH, Makumbi F, et al. Voluntary HIV counseling and testing acceptance, sexual risk behavior and HIV incidence in Rakai, Uganda. AIDS. Mar 25 2005;19(5):503–11.
46.
Mullen PD, Ramirez G, Strouse D, Hedges LV, Sogolow E. Meta-analysis of the effects of behavioral HIV prevention interventions on the sexual risk behavior of sexually experienced adolescents in controlled studies in the United States. J Acquir Immune Defic Syndr. Jul 2002;30 Suppl:S94–105.
47.
Morris M, Kretzschmar M. Concurrent partnerships and transmission dynamics in networks. Soc Netw. 1995;17:299–318.CrossRef
48.
Aral SO. Just one more day: the gap as population level determinant and risk factor for STI spread. Sex Transm Dis. May 2008;35(5):445–6.
49.
Chen MI, Ghani AC, Edmunds J. Mind the gap: the role of time between sex with two consecutive partners on the transmission dynamics of gonorrhea. Sex Transm Dis. May 2008;35(5):435–44.
50.
Pinkerton SD, Layde PM, DiFranceisco W, Chesson HW. All STDs are not created equal: an analysis of the differential effects of sexual behaviour changes on different STDs. Int J STD AIDS. May 2003;14(5):320–8.
51.
Powers KA, Poole C, Pettifor AE, Cohen MS. Rethinking the heterosexual infectivity of HIV-1: a systematic review and meta-analysis. Lancet Infect Dis. Sep 2008;8(9):553–63.
52.
Pequegnat W, NIMH Collaborative HIV/STD Prevention Trial Group. Results of the RCT to Test the Community Popular Opinion Leader (C-POL) Intervention in Five Countries. Paper presented at: XVII International AIDS Conference 2008; Mexico City.
53.
Khumalo-Sakutukwa G, Morin SF, Fritz K, et al. Project Accept (HPTN 043): a community-based intervention to reduce HIV incidence in populations at risk for HIV in sub-Saharan Africa and Thailand. J Acquir Immune Defic Syndr. Dec 1 2008;49(4):422–31.
54.
Cowan FM, Pascoe SJ, Langhaug LF, et al. The Regai Dzive Shiri Project: a cluster randomised controlled trial to determine the effectiveness of a multi-component community-based HIV prevention intervention for rural youth in Zimbabwe-study design and baseline results. Trop Med Int Health. Oct 2008;13(10):1235–44.
55.
Cowan F. Results of the Regai Dzive Shiri Project: Personal Communication.; May 2009.
56.
Cates W, Jr., Hinman AR. AIDS and absolutism—the demand for perfection in prevention. N Engl J Med. Aug 13 1992;327(7):492–4.
57.
UNAIDS. Practical Guidelines for Intensifying HIV Prevention: Towards Universal Access. Geneva 2007.
58.
Piot P, Bartos M, Larson H, Zewdie D, Mane P. Coming to terms with complexity: a call to action for HIV prevention. Lancet. Sep 6 2008;372(9641):845–59.
59.
Merson M, Padian N, Coates TJ, et al. Combination HIV prevention. Lancet. Nov 22 2008;372(9652):1805–6.
60.
Eaton LA, Kalichman S. Risk compensation in HIV prevention: implications for vaccines, microbicides, and other biomedical HIV prevention technologies. Curr HIV/AIDS Rep. Dec 2007;4(4):165–72.
61.
62.
Obasi AI, Cleophas B, Ross DA, et al. Rationale and design of the MEMA kwa Vijana adolescent sexual and reproductive health intervention in Mwanza Region, Tanzania. AIDS Care. May 2006;18(4):311–22.
63.
Jewkes R, Nduna M, Levin J, et al. A cluster randomized-controlled trial to determine the effectiveness of Stepping Stones in preventing HIV infections and promoting safer sexual behaviour amongst youth in the rural Eastern Cape, South Africa: trial design, methods and baseline findings. Trop Med Int Health. Jan 2006;11(1):3–16.
64.
Patterson TL, Orozovich P, Semple SJ, et al. A sexual risk reduction intervention for female sex workers in Mexico: design and baseline characteristics. J HIV AIDS Soc Serv. 2006;5(2):115–37.
Metadata
Title
Behavior Change Interventions to Prevent HIV Infection among Women Living in Low and Middle Income Countries: A Systematic Review
Authors
Sandra I. McCoy
Rugare A. Kangwende
Nancy S. Padian
Publication date
01-06-2010
Publisher
Springer US
Published in
AIDS and Behavior / Issue 3/2010
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-009-9644-9

Other articles of this Issue 3/2010

AIDS and Behavior 3/2010 Go to the issue

Original Paper

Pilot Study Assessing HIV Vaccine Trial Readiness Among Female Sex Workers, Injection and Non-injection Drug Users, and Men Who Have Sex with Men in Spain

Original Paper

Provider-related Barriers to Rapid HIV Testing in U.S. Urban Non-profit Community Clinics, Community-based Organizations (CBOs) and Hospitals

Original Paper

Comparing Couples’ and Individual Voluntary Counseling and Testing for HIV at Antenatal Clinics in Tanzania: A Randomized Trial

Original Paper

Using Electronic Drug Monitor Feedback to Improve Adherence to Antiretroviral Therapy Among HIV-Positive Patients in China

Original Paper

A Randomized Trial to Evaluate the Efficacy of a Computer-Tailored Intervention to Promote Safer Injection Practices Among Drug Users

Brief report

Acceptability of a Non-Woven Device for Vaginal Drug Delivery of Microbicides or Other Active Agents
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits